Hedge Fund - Visium Asset Management

Jacob Gottlieb’s multi-billion-dollar hedge fund Visium Asset Management LP has been making headlines earlier today, as federal authorities filed criminal and civil securities charges against several...

We are seeing a boatload of 13G filing activity at the moment and investment firms disclose their positions as of the end of 2015 (we are not publishing these filings, as they are outdated).

Numerous sources and statistics recently indicated that hedge funds have been severely hit by the current volatile markets.

SAGE Therapeutics Inc (NASDAQ:SAGE) has recently been included in a filing by Jacob Gottlieb's Visium Asset Management.

Jacob Gottlieb’s Visium Asset Management recently filed its latest 13F with the Securities and Exchange Commission for the reporting period of September 30.

A Schedule 13G is a public filing that must be submitted with the SEC by every hedge fund manager or other investor who acquires ownership of more than 5% in a publicly-traded company.

Everybody is talking about Bill Ackman's nearly $2 billion losses in Valeant (VRX). Valeant isn't the only stock that is costing hedge funds billions.

Is it a good time to buy shares of Ascendis Pharma A/S (NASDAQ:ASND)? Jacob Gottlieb thinks so, since his fund, Visium Asset Management, has significantly increased its holding in the company recently...

According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV Technologies S.A.